Free Trial
NASDAQ:CV

CapsoVision (CV) Stock Price, News & Analysis

CapsoVision logo
$4.00 +0.02 (+0.50%)
As of 08/22/2025 04:00 PM Eastern

About CapsoVision Stock (NASDAQ:CV)

Key Stats

Today's Range
$3.90
$4.00
50-Day Range
N/A
52-Week Range
$3.49
$5.72
Volume
18,540 shs
Average Volume
47,501 shs
Market Capitalization
$187.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50
Consensus Rating
Strong Buy

Company Overview

Receive CV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CapsoVision and its competitors with MarketBeat's FREE daily newsletter.

CV Stock News Headlines

Brokers Offer Predictions for CapsoVision FY2028 Earnings
This Crypto Is Set to Explode in January
The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain sight...tc pixel
See More Headlines

CV Stock Analysis - Frequently Asked Questions

CapsoVision's stock was trading at $4.57 at the beginning of 2025. Since then, CV stock has decreased by 12.5% and is now trading at $4.00.

CapsoVision, Inc. (NASDAQ:CV) issued its quarterly earnings data on Thursday, August, 14th. The company reported ($2.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by $1.91. The business had revenue of $3.32 million for the quarter, compared to analysts' expectations of $3.20 million.

CapsoVision (CV) raised $28 million in an IPO on Wednesday, July 2nd 2025. The company issued 5,300,000 shares at a price of $5.00-$5.50 per share. The Benchmark Company and Roth Capital Partners acted as the underwriters for the IPO.

CapsoVision's quiet period expired on Monday, August 11th. CapsoVision had issued 5,500,000 shares in its IPO on July 2nd. The total size of the offering was $27,500,000 based on an initial share price of $5.00. During CapsoVision's quiet period, insiders and any underwriters involved in the IPO were prevented from issuing any research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Shares of CV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/14/2025
Today
8/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical, Medical, And Dental Instruments And Supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:CV
CIK
1378325
Web
N/A
Fax
N/A
Employees
90
Year Founded
N/A

Price Target and Rating

High Price Target
$6.00
Low Price Target
$5.00
Potential Upside/Downside
+37.5%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
46,770,000
Free Float
N/A
Market Cap
$187.08 million
Optionable
N/A
Beta
N/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:CV) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners